WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Travis Kelce downs whiskey shot on slice of bread at Kelce Jam without Taylor Swift
International hot air balloons festival opens in Gansu
AI crucial to NEV supremacy, agree auto execs
Bamboo dance competition held at middle school in Hainan
Candice Swanepoel stuns in a form
Water use remains steady as GDP increases
China hosts 135th Canton Fair in Guangzhou
Nuclear power plant operator sanguine on renewable energy
Bella Hadid goes braless in a thigh
Shanghai to Athens airline route set to launch in April
Kristin Cavallari, 37, ignores critics of her age
Villagers rehearse dragon and lion dance in Andi Village, Shanxi